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Introduction
Surgical site infections (SSI) account for up to 20% of 
healthcare associated infections, [1] which amounts to 
approximately 35,000-40,000 infections in Australia each 
year [2].
As Australia has the highest rate of skin cancer in the 
world, and as the majority of skin cancer is managed in 
general practice [3], GP minor surgery and optimal post-
operative management is a particular issue for Australian 
GPs. It is projected that close to a million surgical procedures 
for both squamous cell carcinoma (SCC) and basal cell car-
cinoma (BCC) will be performed in 2016 [4], the majority of 
these by general practitioners (GPs).
The acceptable rate of SSI following clean minor surgery 
(Class 1) is less than 5% [5], however, the infection rate may 
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Background: Surgical site infection (SSI) after minor surgery in primary care can compromise cosmet-
ic outcomes, delay wound healing and increase costs. In addition to efficacy, adverse effects must be 
considered when considering antibiotic prophylaxis. There is no prior published literature regarding 
the proportion of general practitioners (GPs) who use topical antibiotics as SSI prophylaxis following 
minor surgery.
Objectives: To identify the proportion of GPs in a regional center in Queensland, Australia who apply 
topical antibiotics to wounds prevent SSIs after minor surgery.
Method: A database of 90 GPs was established, and they were invited to complete a questionnaire.
Results: The response rate was 62% (56/90). Topical antibiotics prophylaxis was reported as being 
used always or sometimes in routine practice by 18% (10/56) of participants after both skin lesion 
excision and repair of lacerations. In the context of high-risk situations, on the other hand, use was 
higher. They were more likely to be used in high-risk situations, most frequently in diabetic patients 
(41.0% [23/56]) and immunocompromised patients (46.5% [26/56]).
Conclusions: Evidence-based prescribing of antibiotics is vital. Topical antibiotic prophylaxis is often 
prescribed excessively after clean dermatological surgery, however, in our sample of GPs, only 18% 
used topical antibiotics always or sometimes in their practice.
ABSTRACT
Research  |  Dermatol Pract Concept 2017;7(3):3 17
tionnaire was pilot tested in May 2014 and based on feedback 
was further refined before distribution. The questionnaire 
aimed to investigate topical antibiotic prescribing both in 
routine practice and in the context of high-risk situations. The 
categories of “always and sometimes” were further combined 
for the purposes of interpretation to indicate that topical 
antibiotics were used “ever,” as opposed to “seldom or never.”
Data collection
The questionnaire, information sheet, and consent form were 
individually posted to all GPs in the database. Each practice 
was initially sent an email to inform them of the survey and 
to request the return of the completed questionnaires and 
consent forms. After a period of three months, a second copy 
of the survey was sent to eligible participants with a follow-up 
email. Data from completed questionnaires were de-identified 
and stored securely.
Data analysis
Data collected from the survey was analyzed using Statistical 
Package for Social Sciences (SPSS, Inc. version 22). Participant 
characteristics and outcomes were presented using frequen-
cies and descriptive statistics. Comparisons of outcomes 
were analyzed with a Chi-squared test or Fisher’s exact test 
where appropriate, with a p value less than 0.05 considered 
significant.
Ethical considerations
Ethical approval for the study was obtained from the 
James Cook University Human Research Ethics Committee 
(H5616).
Results
Completed surveys were returned by 56/90 participants 
(62% response rate). The characteristics of those GPs who 
responded are presented in Table 1. Of the participants who 
responded, 53.6% were male, 60% (34/56) were aged 46-55, 
and 34% had a length of practice between 21 and 30 years. 
This is representative of the demographics of GPs in Mackay.
Use of topical antibiotics after excisions and 
lacerations in the context of routine practice
In the context of routine practice, topical antibiotics were 
reported to be used always or sometimes (as opposed to 
seldom and never) to prevent wound infections after minor 
skin excisions by 18% (10/56) of participants. After lacera-
tions, 18% (10/56) of participants also reported using topi-
cal antibiotics always or sometimes (Table 2). There was no 
association between the GP characteristics of age, gender, and 
length of time in practice and the use of topical antibiotics in 
excisions and lacerations.
be higher because of body site, [6,7] the pathology of the 
lesion removed [6-8] or environmental conditions [8,9].
Limited guidelines exist regarding antibiotic prophylaxis 
of dermatological procedures [10-12,13], and those available 
guidelines do not recommend any type of antibiotic to pre-
vent SSI in clean (class 1) minor surgery [11]. The National 
Institute for Health and Care Excellence (NICE) guidelines 
also state “do not use topical antibiotics in wounds healing 
by primary intention to reduce the risk of surgical site infec-
tion.” [12] In practice, antibiotic prophylaxis is prescribed 
excessively or inappropriately for dermatological surgery, in 
general, and it is recommended it be reserved for high-risk 
situations [13-15]. A recent Cochrane Review found moder-
ate quality evidence that topical antibiotics probably prevent 
SSI compared to no treatment (RR 0.61, 95% CI 0.42 to 
0.87), but did not recommend use in clean (class 1) surgery, 
where the baseline infection rate is already low. There was 
insufficient evidence in the review to make judgments about 
adverse events such as allergic contact dermatitis and antibi-
otic resistance [16] that limits the ability to make an overall 
evaluation of the use of topical antibiotics.
Currently, there is no data available to assess the propor-
tion of Australian GPs who use topical antibiotics as SSI 
prophylaxis in wounds healing by primary intention. The 
aim of this study was to identify the proportion of GPs in 
Mackay, Queensland who use topical antibiotics to prevent 
SSI in excisions and lacerations healing by primary intention 
as well as identifying the class of topical antibiotics used and 
clinical and patient factors that may influence this use.
Methods
Study design and setting
All GPs, including GP registrars working within the 4740 
postcode, were initially identified by a search of the Towns-
ville-Mackay Medicare Local Service Finder. Each GP clinic 
was contacted by a study author (PL) to confirm the GPs 
working at that service. Those GPs who were on leave at the 
time of the survey were excluded as were GPs working in 
settings that did not involve minor surgery (women’s health, 
occupational health). A database of 90 GPs was established.
Sample size
Based on an estimated incidence of 50% for our primary 
outcome (incidence of prescribing topical antibiotics), the 
sample size was calculated to be 47 for 95% confidence and 
10% precision.
Questionnaire
The two-page questionnaire was designed by one author (PL) 
with assistance from other authors (CH and JB), using current 
guidelines and literature to ensure content validity. The ques-
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One other study of topical antibiotic use was identified 
in the literature. This was a survey of UK plastic surgeons 
regarding topical chloramphenicol use, which was initially 
conducted in 1999 and then repeated in 2010. In the initial 
survey, 66% of UK plastic surgeons reported using topical 
chloramphenicol ointment in their practice, and in 2010 a 
slightly higher proportion of 72% was reported [17,18]. This 
is higher than the reported rate of 18% in our GP survey 
and may in part be due to a difference in types of surgery or 
patient expectations.
It was interesting that, in the context of routine practice, 
topical antibiotics were reported to be used always or some-
times by the same number of GPs (18%) after excisions as 
lacerations. Excisions are classified as class 1 wounds with 
an acceptable postoperative infection rate of less than 5% 
[5], while lacerations are classified class 3 wounds, with an 
acceptable infection rate of 10-17% [19]. Assuming that the 
relative risk reduction in both clinical situations is the same, 
topical antibiotics would be of more clinical value after lac-
erations than skin excisions, where the likely absolute risk 
reduction in infection would be higher.
In our previous studies of risk factors for infection, we 
established excision from the lower limb as being the most 
significant independent risk factor for SSI, with infection rates 
as high as 30% [6,7,20] and, therefore, in the context of high-
risk practice, the reported high frequency of use of topical 
antibiotics by GPs in excisions from the lower limb (39%) is 
probably justified. The evidence for diabetes as a risk factor 
Class of topical antibiotics used
The different subtypes of topical antibiotics used by GPs in 
any area of their practice are reported in Table 3. The two 
most commonly used antibiotics were chloramphenicol, 
which was reported to be used by 56.6% (30/53) of GPs, 
and mupirocin, which was reported to be used by 43.4% 
(23/53) of GPs.
There was no significant association between GP charac-
teristics and the class of topical antibiotic used.
Use of topical antibiotics in the context of high-
risk situations
The reported use of topical antibiotics was higher in the con-
text of clinical situations that are considered to be at higher 
risk for infection (Table 4). A total of 41.0% (23/56) of GPs 
reported ever (always or sometimes) using topical antibiot-
ics in diabetic patients, 46.5% (26/56) of GPs reported the 
same for immunocompromised patients, 46.5% (26/56) for 
patients with previous surgical site infection, 39.3% (22/56) 
for lower limb sites, 17.9% (10/56) for upper limb sites and 
33.4% (19/56) for facial wounds. GPs who had been in 
practice for less than ten years reported they were signifi-
cantly more likely to use antibiotics always or sometimes for 
immunocompromised patients (p= 0.01), and patients with 
previous surgical site infections (p= 0.02) compared with GPs 
who had been in practice for a longer period.
Discussion
The judicious use of antibiotics is critical. In addition to 
efficacy, health system costs, side effects, and the rise in anti-
biotic resistance must be taken into account when considering 
antibiotic use prophylactically. While there is much discussion 
about GP oral antibiotic use, we believe that this is the first 
study to establish the frequency of topical antibiotic use in 
the context of minor surgery by GPs.
TABLE 1. Characteristics of respondents
Characteristics
N (%) 
N=56
Gender Male
Female
30 (53.6)
26 (46.4)
Age in years ** < 30
30-44
45-59
60 and older
2 (3.6)
13 (23.2)
34 (60.7)
5 (8.9)
Length of practice 
in GP (Y)
10 years or less
11-20
21-30
More than 30 years
15 (26.8)
16 (28.6)
19 (33.9)
6 (10.7)
** 2 participants did not report age
TABLE 2. Frequency of topical antibiotic use in 
the context of routine practice
Frequency Excisions % Lacerations %
Never 29 (51.8) 36 (64.3)
Seldom 17 (30.4) 10 (17.9)
Sometimes  8 (14.3)  9 (16.1)
Always  2 (3.6)  1 (1.8)
TABLE 3. Types of topical antibiotics used**
Antibiotic Used Frequency N (%)*
Mupirocin 23 (43.4)
Chloramphenicol 30 (56.6)
Polymixin B sufate 1 (1.9)
bacitracin zinc, neomycin 
sulfate, polymyxin B sulfate 
combination ointment (TAO)
1(1.9)
Neomycin 2 (3.8)
Not used 10 (18.8)
* There was missing data from 3 GPs, denominator=53 GPs
** This question referred to topical antibiotics used in any 
 clinical situation by GPs
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Implications for General Practice
Evidence-based prescribing of antibiotics is vital. In practice, 
antibiotic prophylaxis is often prescribed excessively or inap-
propriately for dermatological surgery [13-15]; however, in 
our sample of GPs only 18% used topical antibiotics always 
or sometimes in their practice. It is evident that topical anti-
biotics are used too frequently for prophylaxis against infec-
tion after clean surgery and that they should be reserved for 
high-risk situations.
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